Aravive Total Current Liabilities 2011-2026 | ARAV

Annual Total Current Liabilities Aravive

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
22.1 M	17.9 M	9.46 M	4.97 M	1.94 M	5.59 M	-	8.83 M	6.92 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
22.1 M	1.94 M	9.72 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	63.1 M	$ 2.63	-1.22 %	$ 16.5 M	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	1.61 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	9.31 M	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Akari Therapeutics, Plc AKTX	12.4 M	$ 3.41	-3.67 %	$ 230 B	Britain
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	36.6 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	15.7 M	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	1.47 B	$ 316.2	-4.28 %	$ 41.4 B	USA
Alpine Immune Sciences ALPN	58 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	6.18 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	9.71 M	-	4.14 %	$ 49.1 M	USA
Atreca BCEL	16.3 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Завод ДИОД DIOD	105 M	-	-	-	Russia
Фармсинтез LIFE	1.02 B	-	-	-	Russia
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	4.34 M	$ 0.89	-	$ 4.85 M	China
Applied Therapeutics APLT	71.2 M	-	-	$ 8.42 M	USA
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Teligent, Inc. TLGT	23.1 M	-	-13.85 %	$ 16.1 M	USA
Cerus Corporation CERS	101 M	$ 1.8	-2.7 %	$ 343 M	USA
AbbVie ABBV	43.3 B	$ 202.28	-2.11 %	$ 358 B	USA
Aquestive Therapeutics AQST	47.6 M	$ 4.04	-1.28 %	$ 432 M	USA
Viela Bio, Inc. VIE	46 M	-	-	$ 2.91 B	USA
Coherus BioSciences CHRS	140 M	$ 1.63	-2.69 %	$ 191 M	USA
AbCellera Biologics ABCL	64.3 M	$ 3.32	-2.06 %	$ 992 M	Canada
Arcturus Therapeutics Holdings ARCT	36.4 M	$ 8.12	-1.22 %	$ 222 M	Israel
Ardelyx ARDX	88.6 M	$ 5.8	-2.93 %	$ 1.4 B	USA